Positioning no disclosures inside 60 days, left as found
Options put/call open interest 1.58, read 2026-10-27
Ethical does not pass the values gate
Price17.26 USD
Fair value21.25
Ethical score70.0/100
Our investment reviews on this name
2026-10-02Read Accumulation14.41+19.8% to today ✓Markdown gives way to Accumulation after a 9% rise in 2 weeks
2026-09-16Read Markdown13.17+31.1% to today Distribution gives way to Markdown after an 11% slide in 4 weeks
2026-08-16Read Distribution14.75+17.0% to today Markdown gives way to Distribution after a 16% slide in 6 weeks
2026-07-02Read Markdown17.64-2.2% to today ✓First review on file: Markdown
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
V.F. Corporation holds its Accumulation at $17.26. The statistical read favours the buyers, held for 41 days.
As held on the ledger · 2026-10-23
Phase
Accumulation
Quantitative state
The statistical read favours the buyers, held for 41 days
Price at the screen
$17.26
Valuation
25.68 trailing · 13.02 forward price to earnings
Values screen
FAIL· score 70.0
Beta
1.58
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
53.64%
Below 33%
Interest-bearing debt is 53.6% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.13%
Below 33%
Cash held in interest-bearing accounts and securities is 0.1% of assets, under the one-third limit.
Pass
Receivables
24.24%
Below 49%
Money owed to the company is 24.2% of assets, under the 49% limit.
Pass
Revenue purity
0.19%
Below 5%
Only 0.2% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
V.F.'s business is in a permissible area, but its interest-bearing debt is about 54% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when VFC's ethical verdict changes
Today VFC does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-10-23 screen. The gold marker is the market price at the same screen. A 23.1% margin of safety to the base estimate.
Third-party analyst targets: 22 covering, consensus Buy. The average target sits −2% from the screen price.
Reading the gap · Our model sees value the Street hasn't fully caught up to yet.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-23 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Apparel maker looks cheap but offers slim growth
Every winter jacket or hiking boot sold in a shopping centre still has to move through the same slow cycle of seasons and spending moods that no brand fully controls. V.F. Corporation sits at a forward multiple of 12.4 times with a 32 percent gap to our fair value yet revenue is advancing only 1 percent a year and margins sit at 6 percent. The ethical screen clears but the opportunity rating stays at none because the business shows no durable edge in a crowded market.
The 22 percent return on equity looks attractive on paper yet the company operates in a cyclical sector where low multiples often signal peak earnings rather than bargains. Twenty one analysts rate the shares a hold with a median target of 18 dollars, below our own assessment, and the unknown moat leaves little room for outperformance once consumer spending turns.
Risk centres on fashion shifts and economic sensitivity that could compress those margins further without any visible catalyst for faster top line growth. Analysis, not advice.
The risks · The things to watch: it already moves more than the market on an average day; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
VFC trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-28Accumulation$17.46+0.0%Entry 15
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 28%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (21 analysts) rates it hold, with a mean price target of $20. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27Accumulation$17.46+0.0%Entry 14
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 28%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (21 analysts) rates it hold, with a mean price target of $20. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-26Accumulation$17.46+0.0%Entry 13
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 28%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (21 analysts) rates it hold, with a mean price target of $20. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Accumulation$17.46+0.0%Entry 12
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 28%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (21 analysts) rates it hold, with a mean price target of $20. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-24Accumulation$17.46+0.0%Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 28%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (21 analysts) rates it hold, with a mean price target of $20. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-23Accumulation$17.46+0.0%Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 28%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (21 analysts) rates it hold, with a mean price target of $20. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-22Accumulation$17.46+0.0%Entry 9
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 28%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (21 analysts) rates it hold, with a mean price target of $20. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-21Accumulation$17.46+5.9%Entry 8
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 5.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 28%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (21 analysts) rates it hold, with a mean price target of $20. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-16Accumulation$16.48+14.4%Entry 7
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 14.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 5% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 28%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (21 analysts) rates it hold, with a mean price target of $20.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 9.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 5% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 28%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (21 analysts) rates it hold, with a mean price target of $20.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
